Yu D, Gordon J D, Zheng J, Panesar S K, Riggs K W, Rurak D W, Abbott F S
Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada.
J Chromatogr B Biomed Appl. 1995 Apr 21;666(2):269-81. doi: 10.1016/0378-4347(94)00585-s.
An improved method for the quantitative determination of valproic acid (VPA) and sixteen of its metabolites has been developed using gas chromatography-mass spectrometry with selected-ion monitoring. The method is applicable to serum or urine and all metabolites are measured in a single chromatographic run of 29.5 min. Ions selected for quantitative purposes were the characteristic [M-57]+ ions of the tert.-butyldimethylsilyl (tBDMS) derivatives. The method utilizes heptadeuterated VPA as well as six heptadeuterated metabolites as internal standards [i.e. 2-[2H7]propyl-2-pentenoic acid (2-ene[2H7]VPA), 2-[2H7]propyl-4-pentenoic acid (4-ene[2H7]VPA), 2-[2H7]propyl-3-oxopentanoic acid (3-keto[2H7]VPA), 2-[2H7]propyl-4-oxopentanoic acid (4-keto[2H7]VPA), 2-[2H7]propyl-3-hydroxypentanoic acid (3-OH[2H7]VPA), 2-[2H7]propyl-5-hydroxypentanoic acid (5-OH[2H7]VPA)]. The method demonstrates very good accuracy and precision over a large range of concentrations for VPA and all metabolites measured in both human and sheep biological fluids. The assay was applied to the analysis of VPA and metabolites in serum and urine samples collected from three non-pregnant ewes following intravenous bolus administration of a mixture of VPA and [13C4]VPA. Sheep were observed to produce measurable quantities of the majority of metabolites found in humans, with the notable exception of the di-unsaturated compounds (i.e. 2,3'-diene VPA and 2,4-diene VPA). The pharmacokinetics and metabolism of VPA and [13C4]VPA appear to be equivalent in the sheep model. The elimination half-life of VPA and [13C4]VPA in the ewe were estimated to be approximately 3.5 +/- 0.4 and 3.2 +/- 0.4 h, respectively.
已开发出一种改进的方法,用于使用气相色谱 - 质谱联用选择离子监测法定量测定丙戊酸(VPA)及其十六种代谢物。该方法适用于血清或尿液,所有代谢物在29.5分钟的单次色谱运行中进行测量。用于定量目的选择的离子是叔丁基二甲基甲硅烷基(tBDMS)衍生物的特征性[M - 57]+离子。该方法利用十七氘代VPA以及六种十七氘代代谢物作为内标[即2 - [2H7]丙基 - 2 - 戊烯酸(2 - 烯[2H7]VPA)、2 - [2H7]丙基 - 4 - 戊烯酸(4 - 烯[2H7]VPA)、2 - [2H7]丙基 - 3 - 氧代戊酸(3 - 酮[2H7]VPA)、2 - [2H7]丙基 - 4 - 氧代戊酸(4 - 酮[2H7]VPA)、2 - [2H7]丙基 - 3 - 羟基戊酸(3 - OH[2H7]VPA)、2 - [2H7]丙基 - 5 - 羟基戊酸(5 - OH[2H7]VPA)]。该方法在人和绵羊生物流体中测量的VPA和所有代谢物的大范围浓度上都显示出非常好的准确度和精密度。该测定法应用于分析从三只未怀孕母羊静脉推注VPA和[13C4]VPA混合物后收集的血清和尿液样本中的VPA和代谢物。观察到绵羊产生了人类中发现的大多数可测量量的代谢物,但二不饱和化合物(即2,3'-二烯VPA和2,4 - 二烯VPA)明显除外。VPA和[13C4]VPA在绵羊模型中的药代动力学和代谢似乎是等效的。母羊中VPA和[13C4]VPA的消除半衰期估计分别约为3.5±0.4小时和3.2±0.4小时。